Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . January 15th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Breast Cancer - Chemotherapy, Tamoxifen Treatment Can Impair Physical Function Over Time
Non-Hodgkin Lymphoma - Complement Activation May Mediate Rituximab Complications
Cancer Gene Therapy - Cascade Of Events Needed For p53 To Suppress Tumors
Cancer Therapies - Researchers Seek To Block Tumor Growth By Interfering With Polyamines
Kaposi Sarcoma - Glutathione Analogue Limits Tumor Vascularization In Murine Model
Prostate Cancer - Lycopene, Antioxidant In Tomatoes, May Reduce Risk
Ultrasound - Doppler Images Of Arteries Provide Useful Assessment For Breast Status
Appointments - Allos Therapeutics Names President and Chief Executive Officer
Appointments - Hamilton Jordan Named to Proxima Therapeutics Board of Directors
Breast Cancer - Sequential Use Of Doxorubicin And Docetaxel Produce High Pathologic Response Rate
Breast Imaging - CTI Sponsors Clinical Study Using Thermal Imaging System
Colon Diseases - Mayo Clinic Receives Patents From Procter & Gamble to Develop Drug Delivery Vehicle
Education - Melanoma Web Sites Give Incomplete, Wrong Information, Study Says
Enzymology - MethylGene and ChemBridge Sign Research Agreement
Esophageal Cancer - Clinical Phase II Compound Gets Orphan Drug Status in U.S.
Ethics - General Accounting Office Probes Tainted Medical Research
Head and Neck Cancer - Mast Cells Implicated In Esophageal Carcinoma Angiogenesis
Lung Cancer - Clinical Data From Phase I/II GVAX Vaccine Trial Updated
Lung Cancer - Tumor Size A Surgical Guide For Some But Not All Non-Small Cell Cancers
Non-Hodgkin Lymphoma - Oxaliplatin-Based Chemotherapy Safe, Effective
Prostate Cancer - AstraZeneca Submits Supplemental NDA for Bicalutamide 150 mg
Prostate Cancer - CG7870 Shows Synergistic Antitumor Activity With Chemotherapy
Prostate Cancer - Myriad Genetics Submits Clinical Trial for Flurizan to FDA
Prostate Cancer - Sicor Signs Licensing and Development Agreement With Epic Therapeutics
Research - Xenerex Reaches Second Stage of Antibody Agreement With Eos
Skin Cancer - PhotoCure Licenses Metvix to Galderma
Tobacco Use - Researchers Hunt For Genetic Link
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
